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The gut mucosa is exposed to a large community of commensal bacteria that are required for the processing
of nutrients and the education of the local immune system. Conversely, the gut immune system generates
innate and adaptive responses that shape the composition of the local microbiota. One striking feature of
intestinal adaptive immunity is its ability to generate massive amounts of noninflammatory immunoglobulin
A (IgA) antibodies through multiple follicular and extrafollicular pathways that operate in the presence or
absence of cognate T-B cell interactions. Here we discuss the role of intestinal IgA in host-commensal
mutualism, immune protection, and tolerance and summarize recent advances on the role of innate immune
cells in intestinal IgA production.Introduction
The gastrointestinal mucosa is a unique environment that be-
comes exposed to a massive and diverse microbial ecosystem
shortly after birth (Macpherson, 2006). The stomach and proxi-
mal segments of the small intestine, including the duodenum
and jejunum, have relatively low bacterial densities of approxi-
mately 103–105 organisms per gram of luminal contents, at least
in mice. Higher bacterial densities of 108 organisms per gram can
be found in the ileum, which is the distal portion of the small
intestine. In the large intestine or colon, bacteria can reach a den-
sity of 1010–1012 organisms per gram and comprise more than
1000 species, including obligate anaerobes, such as Bacter-
oides, bifidobacteria, fusobacteria, and peptostreptococci, as
well as obligate and facultative aerobes, such as enterobacteria
and lactobacilli. Because of this massive colonization, the num-
ber of prokaryotic cells in our body is estimated to exceed that of
eukaryotic cells by one order of magnitude.
In general, intestinal bacteria establish a mutualistic relation-
ship with the human host. The peaceful nature of this relationship
can be traced in the word commensal, which originates from the
Latin cum mensa, ‘‘sharing a table.’’ Indeed, the intestinal lumen
provides bacteria with a stable habitat rich in energy sources de-
rived from the ingested food (Macpherson and Harris, 2004).
Conversely, bacteria breakdown otherwise indigestible food
components, generate essential nutrients, compete with incom-
ing invasive species, stimulate the growth and protective func-
tions of intestinal epithelial cells, and facilitate the development
of the intestinal immune system (Macpherson and Harris, 2004;
Rakoff-Nahoum et al., 2004; Rhee et al., 2004). Thus, it is not sur-
prising that the intestine has evolved multiple immune strategies
to confine commensals to the intestinal lumen while preserving
their number and composition. An additional remarkable feature
of the intestine is its capacity to select appropriate effector and
regulatory immune mechanisms to neutralize pathogens while
preventing bystander tissue damage (Holmgren and Czerkinsky,
2005). In this fashion, the intestine provides immune protection
without compromising the integrity of the epithelial barrier.
A key intestinal strategy to generate immune protection in
a noninflammatory manner is the production of immunoglobulin740 Immunity 28, June 2008 ª2008 Elsevier Inc.A (IgA), the most abundant antibody isotype produced in our
body (Macpherson et al., 2008). IgA provides mucosal immune
protection as a result of its ability to interact with the polymeric
Ig receptor (pIgR), an antibody transporter expressed on the ba-
solateral surface of epithelial cells (Mostov and Deitcher, 1986).
After binding to pIgR, IgA dimers secreted by intestinal B cells
translocate to the surface of epithelial cells, thereby generating
secretory IgA (SIgA) complexes that play multiple protective
roles (Mestecky et al., 1999). SIgA promotes immune exclusion
by entrapping dietary antigens and microorganisms in the mu-
cus, downmodulates the expression of proinflammatory bacte-
rial epitopes on commensal bacteria, and, in general, promotes
the maintenance of appropriate bacterial communities within
specific intestinal segments (Fagarasan et al., 2002; Peterson
et al., 2007; Phalipon et al., 2002). In addition, SIgA blocks or
sterically hinders microbial components involved in epithelial
attachment, mediates intraepithelial neutralization of incoming
pathogens and microbial inflammatory products, and facilitates
antigen sampling by binding to microfold (M) cells, an epithe-
lial-like cell type specialized in antigen-capturing functions
(Brandtzaeg et al., 1999; Fernandez et al., 2003; Huang et al.,
2005; Kadaoui and Corthesy, 2007; Mantis et al., 2002; Rhee
et al., 2004). Furthermore, IgA dimers locally released by plasma
cells remove microorganisms that have breached the epithelial
barrier in two ways: by transporting them back into the lumen
through the pIgR and by promoting their clearance via FcaRI
(also known as CD89), an IgA receptor expressed by dendritic
cells (DCs), neutrophils, and other phagocytes (Pasquier et al.,
2005; Phalipon and Corthesy, 2003).
Here we discuss the function of intestinal IgA antibodies, the
follicular and extrafollicular inductive sites for intestinal IgA pro-
duction, the T cell-dependent and T cell-independent pathways
regulating intestinal IgA responses, and the mechanisms medi-
ating homing of IgA-producing B cells to the intestinal lamina
propria.
Follicular Inductive Sites for Intestinal IgA Production
Craig and Cebra were the first to show that Peyer’s patches are
a source of IgA precursor cells (Craig and Cebra, 1971). Using an
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ReviewFigure 1. Intestinal IgA Responses in Mice and Humans
In mice (left model), DCs lodged in the subepithelial dome of Peyer’s patches capture bacteria or antigen internalized by M cells or by epithelial cells (ECs) via
receptor-mediated endocytosis. These DCs migrate to the interfollicular region (IFR) of Peyer’s patches, where they present antigen to CD4+ T cells. Antigen-
activated CD4+ T cells elicit IgA class switching by stimulating IgM+IgD+ B cells through CD40L and TGF. A subset of Peyer’s patch DCs, TNF-a+iNOS+ DCs,
enhance IgA class switching by upregulating the expression of the TGF-b receptor on B cells through nitric oxide (NO). In the presence of retinoic acid (RA),
IgA+ B cells upregulate the expression of CCR9 and a4b7 and thereafter migrate to the lamina propria, where they differentiate into plasma cells that release
dimeric IgA antibodies. This T cell-dependent pathway yields high-affinity, monoreactive IgA antibodies that preferentially target pathogens and toxins. IgA class
switching can also take place in the lamina propria via a T independent mechanism that involves activation of B-1 cells and possibly other IgM+IgD+ B cell subsets
by DCs, including TNF-a+iNOS+ DCs. These DCs release innate IgA class-switch-inducing factors, such as BAFF, APRIL, TGF-b, and NO, as well as IgA secre-
tion-inducing factors, such as IL-6 and RA, after sensing bacteria through TLRs. NO amplifies IgA class switching by enhancing BAFF and APRIL production by
DCs. This T cell-independent pathway preferentially yields low-affinity, polyreactive IgA antibodies to commensal bacteria.
In humans (right model), CD4+ T cells elicit IgA1 class switching by activating Peyer’s patch IgM+IgD+ B cells through CD40L and TGF-b. The resulting IgA1+ B
cells migrate to the lamina propria through a mechanism presumably similar to that utilized by mouse IgA+ B cells. In the lamina propria, IgA1+ B cells sequentially
switch to IgA2 in response to APRIL and IL-10 released by TLR-activated ECs. Also, DCs can release these cytokines in response to TSLP produced by ECs. In
the lamina propria, additional IgM+IgD+ B cells can undergo direct class switching from IgM to IgA1 or IgA2 in response to BAFF or APRIL and IL-10. In general,
IgA2 is more resistant to bacterial proteases than IgA1 and may therefore have a longer half-life in the lumen of the distal intestinal tract.elegant adoptive-transfer system based on different Ig allotypes,
they demonstrated that cells derived from Peyer’s patches were
able to replenish lethally irradiated rabbits with IgA-producing
cells. They clearly showed that the intestinal lamina propria of
recipient animals was repopulated with IgA-secreting cells of
donor origin after transfer of Peyer’s patches, but not of popliteal
lymph node cells.
Peyer’s patches are characterized by three important fea-
tures. First, Peyer’s patches include germinal centers that pro-
mote the interaction between antigen-specific T cells and B cells
as well as the expression of activation-induced cytidine deami-
nase (AID), a B cell-specific enzyme required for the diversifica-
tion of Ig genes through class-switch DNA recombination (CSR)
and somatic hypermutation (Muramatsu et al., 2000). Second,
Peyer’s patches contain a higher proportion of B cells versus T
cells (four to six times more) as compared to peripheral lymph
nodes (Stevens et al., 1982). Third, Peyer’s patches are rich in
cytokines with IgA-inducing functions, including transforming
growth factor b (TGF-b) (Gonnella et al., 1998).
TGF-b cooperates with CD40 ligand (CD40L, also known as
CD154), a tumor necrosis factor (TNF) family member expressedby CD4+ T cells, to trigger IgA CSR and generate antigen-spe-
cific IgA+ B cells (Figure 1), which represent nearly 70% of germi-
nal-center B cells in Peyer’s patches (Butcher et al., 1982; Cazac
and Roes, 2000; Cerutti, 2008b; Coffman et al., 1989; Islam et al.,
1991; McIntyre et al., 1995; Shockett and Stavnezer, 1991).
Indeed, B cell-conditional TGF-b-receptor-deficient mice show
severely impaired steady-state and antigen-induced IgA re-
sponses both systemically and in intestinal sites (Cazac and
Roes, 2000). In addition to TGF-b, Peyer’s patches contain inter-
leukin-4 (IL-4), IL-6, and IL-10, which facilitate the expansion of
IgA-expressing B cells and their differentiation to IgA-secreting
plasma cells (Defrance et al., 1992; Fayette et al., 1997; Okahashi
et al., 1996; Sato et al., 2003; Xu-Amano et al., 1993).
Peyer’s patches are covered by the follicle-associated epithe-
lium (Figure 1), an epithelial area rich in M cells (Neutra and Ko-
zlowski, 2006). M cells are specialized epithelial cells that deliver
antigen from the gut lumen to intra- and subepithelial DCs
through a vesicular transport system (Neutra, 1999). Not all anti-
gens can gain access to M cells, given that size restrictions are
set by a glycocalix (Frey et al., 1996). Antigen-loaded DCs
migrate from epithelial and subepithelial areas to the T cell-richImmunity 28, June 2008 ª2008 Elsevier Inc. 741
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polarized T helper type-2 (Th2) response characterized by the
release of noninflammatory cytokines with B cell-activating func-
tions, including IL-4 (Rimoldi et al., 2005). This response requires
the ‘‘conditioning’’ of DCs by epithelial cells via thymic stromal
lymphopoietin (TSLP), an IL-7-like cytokine (Figure 2). TSLP
stimulates DC production of IL-10, an IgA-inducing cytokine
that inhibits the generation of proinflammatory Th1 cells releas-
ing interferon-g (IFN-g) (Rimoldi et al., 2005). This inhibitory effect
stems from the ability of TSLP to block DC production of IL-12,
a cytokine essential for the initiation of Th1 responses (Rimoldi
et al., 2005). Thus, intestinal epithelial cells may educate DCs
to initiate noninflammatory T cell-dependent immune responses
in Peyer’s patches, including IgA responses.
Figure 2. Putative Role of IgA in Intestinal Tolerance and
Homeostasis
Intestinal M cells transfer IgA-bound antigen from the lumen to DCs. In the
presence of TSLP and other epithelial cell (EC) products, possibly including
retinoic acid (RA), TGF-b, and IL-10, multiple subsets of Peyer’s patch DCs
initiate noninflammatory CD4+ T cell responses. By blocking DC production
of IL-12 and inducing DC production of IL-10, TSLP prevents intestinal DCs
from initiating proinflammatory Th1 responses, including IFN-g-dependent ac-
tivation of macrophages and cytotoxic T lymphocytes (CTLs). The resulting
Th2 response triggers IgA (and IgG) class switching and production by activat-
ing B cells via CD40L (not shown) as well as IL-4 and IL-10. By upregulating DC
release of TGF-b, IL-6, IL-27, and RA, TSLP alone or combined with other
epithelial factors might also initiate Treg, Tr1, and Th17 cell responses. Treg
cells dampen Th1-Th2 immunity through contact-dependent mechanisms
and TGF-b, whereas Tr1 cells and regulatory-stage Th17 cells attenuate
Th1-Th2 immunity via IL-10. Treg, Tr1, and Th17 cells might also trigger IgA
(but not IgG) class switching and production by activating B cells via CD40L
(not shown) as well as TGF-b and IL-10. Intestinal Treg, Tr1, and Th17 cell re-
sponses might be further amplified by TGF-b, IL-10, IL-6, and IgA derived from
B cells.742 Immunity 28, June 2008 ª2008 Elsevier Inc.TSLP-conditioned DCs may further enhance IgA production
by releasing TGF-b (I.D. Iliev and M.R., unpublished data). How-
ever, the finding that mice with leukocytes lacking avb8 integrin,
which is required for the activation of TGF-b (Travis et al., 2007),
have increased serum IgA concentrations might argue against
a prominent role of DCs in TGF-b-induced IgA CSR. Alterna-
tively, TSLP-conditioned DCs may generate CD4+ T cell subsets
with both IgA-inducing and regulatory functions (Figure 2). In-
deed, TSLP-conditioned DCs release IL-6 (Rimoldi et al.,
2005), which cooperates with additional DC mediators, including
TGF-b, retinoic acid, and IL-27, to induce CD4+CD25+Foxp3+ T
regulatory (Treg) cells (I.D. Iliev and M.R., unpublished data),
CD4+CD25Foxp3 T regulatory type 1 (Tr1) cells, and regula-
tory Th17 cells (Li and Flavell, 2008). By releasing TGF-b and
IL-10, Treg, Tr1, and Th17 cells may not only promote intestinal
homeostasis and tolerance, but also stimulate intestinal B cell
production of IgA (Cerutti et al., 1998; Defrance et al., 1992; Fay-
ette et al., 1997; Li and Flavell, 2008). Conversely, IgA-producing
B cells and their precursors might enhance the generation of
Treg, Tr1, and Th17 cells by releasing IL-6, IL-10, and TGF-b
(Cerutti et al., 1998; Zan et al., 1998; Fillatreau et al., 2008).
SIgA could amplify this process as a result of its ability to trans-
port antigen from the lumen to DCs via M cells (Kadaoui and
Corthesy, 2007). In the presence of TSLP and possibly other
epithelial factors, these antigen-loaded DCs would initiate anti-
gen-specific Treg, Tr1, and Th17 cell responses as described
earlier. Although attractive, this model needs to be tested in
cell-type-specific protein-deficient systems. In this regard,
CD4+ T cell-specific TGF-b-deficient mice showed increased
IgA production, at least in the systemic compartment and under
steady-state conditions (M.O. Li and R.A. Flavell, personal com-
munication). Should this observation be extended to the intesti-
nal compartment and to postimmunization conditions, one may
conclude that intestinal IgA responses require a TGF-b-produc-
ing cell type different from CD4+ T cells for their induction. In
agreement with this possibility, DCs, epithelial cells, stromal
cells, mast cells, and B cells are good producers of TGF-b (Baby-
atsky et al., 1996; Fagarasan et al., 2001; Gonnella et al., 1998;
Zan et al., 1998).
In addition to TGF-b, Peyer’s patch DCs may utilize retinoic
acid, IL-6, and inducible nitric-oxide synthase (iNOS) to enhance
intestinal IgA responses (Figure 1). Retinoic acid drives intestinal
IgA production through an elusive mechanism that might affect
IgA CSR or, more likely, the differentiation of IgA class-switched
B cells into IgA-secreting plasma cells. Furthermore, retinoic
acid confers gut-homing properties to IgA class-switched B cells
through its ability to upregulate CCR9 and a4b7 expression on
these cells (Mora et al., 2006). As for IL-6, this cytokine enhances
intestinal IgA production by promoting the differentiation of IgA-
expressing B cells into plasma cells (Sato et al., 2003). Finally,
iNOS enhances intestinal IgA class switching through a mecha-
nism involving upregulation of the TGF-b receptor on Peyer’s
patch B cells (Tezuka et al., 2007).
In general, iNOS has a multifunctional role in the immune sys-
tem, and therefore it may not be surprising that both systemic
and intestinal IgA responses are decreased in iNOS-deficient
mice (Nathan, 2006; Tezuka et al., 2007). Consistent with prior
observations showing that innate immune cells express iNOS
upon activation of Toll-like receptors (TLRs) by microbial ligands
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ing molecule, to express iNOS (Tezuka et al., 2007). Interestingly,
iNOS expression in the intestine is largely restricted to a discrete
subset of TNF-a+iNOS+ DCs. When adoptively transferred into
iNOS-deficient mice, lamina propria TNF-a+iNOS+ DCs from
wild-type mice restore IgA production (Tezuka et al., 2007), con-
firming the central role of DCs in intestinal IgA responses. None-
theless, the presence of TNF-a+iNOS+ DCs in Peyer’s patches
and their relationship with known intestinal DC subsets remain
unclear. In this regard, it must be noted that several populations
of DCs have been described in Peyer’s patches, each character-
ized by a distinctive CD11b, CD11c, CD8, CX3CR1, and CCR6
expression pattern and by different immune functions (Iwasaki,
2007; Rescigno, 2006).
Peyer’s Patches in the Response to Pathogens
Peyer’s patches are critical to initiate antigen-specific immune
response to pathogens capable of penetrating M cells. One of
these pathogens is Salmonella typhimurium, a bacterium
equipped with a type-III secretion system that permits the inva-
sion of nonphagocytic cells (Martinoli et al., 2007). Salmonella
strains deficient for the expression of the invA gene, which is in-
volved in the formation of a productive type III secretion system,
neither enter Peyer’s patches nor induce formation of fecal-
antigen-specific IgA. However, these strains can still enter the
lamina propria, presumably via a DC-mediated mechanism, and
then reach the mesenteric lymph node and the spleen, where
they induce IgG production (Martinoli et al., 2007). Notably,
mice vaccinated with strains of Salmonella unable to elicit a fecal
IgA response become infected if challenged with virulent Salmo-
nella through the oral route, suggesting that antigen-specific IgA
antibodies exert a protective role in the intestinal mucosa.
Together, these data tell us that protective IgA responses to
pathogens are predominantly initiated in Peyer’s patches. A sim-
ilar scenario has been described for commensal bacteria. Enter-
obacter cloacae injected intragastrically in wild-type mice can be
detected in DCs from Peyer’s patches and mesenteric lymph no-
des (Macpherson and Uhr, 2004). This localization is associated
with induction of commensal-specific IgA responses. However,
bacteria cannot be recovered from the spleen, suggesting that
mesenteric lymph nodes are important to exclude commensals
from the systemic immune system. It remains to be established
how noninvasive commensal species gain access to Peyer’s
patches. One possibility is that commensal bacteria first become
opsonized by natural polyreactive IgA antibodies and then un-
dergo IgA-mediated apical-to-basal transepithelial migration
across M cells (Kadaoui and Corthesy, 2007; Mantis et al.,
2002). Interestingly, IgA responses in mesenteric lymph nodes
could also occur in response to transcutaneous immunization,
suggesting the existence of a functional link between the skin
and mucosal sites (Chang et al., 2008).
Payer’s Patches as the Major Site for the Induction
of Antigen-Specific Responses
IgA CSR can also take place in isolated lymphoid follicular struc-
tures that are characterized by a cellular composition similar to
that of Peyer’s patches (Hamada et al., 2002; Moghaddami
et al., 1998). These isolated lymphoid follicles are lined by a spe-
cialized epithelium containing M cells and thus should mount IgAresponses through pathways similar to those utilized by Peyer’s
patches. Mice treated postnatally with LTbR-Ig, a fusion protein
of lymphotoxin-b receptor (LTbR) and IgG Fc, showed reduced
size and numbers of Peyer’s patches and lacked isolated
lymphoid follicles but were still able to generate antigen-specific
mucosal IgA responses after oral immunization, although to
a lesser extent than control mice (Yamamoto et al., 2004).
Mice treated in utero with both TNF receptor (TNF-R) of 55
kDa-Ig and LTbR-Ig lacked Peyer’s patches and mesenteric
lymph nodes but retained intact isolated lymphoid follicles
(Yamamoto et al., 2004). These mice failed to induce antigen-
specific IgA responses after oral immunization, although having
unaltered intestinal IgA antibodies. Together, these findings
demonstrate that Peyer’s patches play a key role in the induction
of specific IgA responses to orally administered antigens. They
also indicate that isolated lymphoid follicles have a marginal
role in these responses.
Remarkably, Peyer’s patches do not absolutely require ger-
minal centers to initiate antigen-specific antibody responses.
Indeed, mice lacking CD28, a B7-binding T cell costimulatory
molecule necessary for germinal-center formation, not only re-
tain IgA-producing plasma cells in the intestinal lamina propria
but can also mount high-affinity IgA antibodies to an orally ad-
ministered T cell-dependent antigen (Gardby et al., 2003). In
contrast, CD28-deficient mice cannot mount specific antibody
responses when challenged with a T cell-dependent antigen
through a systemic route (Gardby et al., 2003). This evidence
indicates that Peyer’s patches can generate high-affinity IgA
antibodies in the absence of canonical cognate T-DC or T-B
cell interactions in the germinal center. The unique nature of
Peyer’s patches is further emphasized by studies showing that
Peyer’s patch B cells do not need to express surface Ig recep-
tors (also known as B cell antigen receptor, BCR) to produce an-
tigen-specific IgA antibodies (Casola et al., 2004). This produc-
tion, rather, requires antigen signaling via TLRs as well as help
from CD4+ T cells (Casola et al., 2004). Thus, it is tempting to
speculate that Peyer’s patches utilize both canonical and nonca-
nonical pathways for the generation of IgA antibodies to specific
T cell-dependent antigens.
Extrafollicular Inductive Sites for Intestinal
IgA Production
Although important, Peyer’s patches are not essential for intes-
tinal IgA production. Indeed, mice treated during gestation with
an LTbR-Ig fusion protein do not develop Peyer’s patches and
yet retain IgA-producing plasma cells in the intestinal lamina
propria (Yamamoto et al., 2004). These mice probably utilize
mesenteric lymph nodes and isolated lymphoid follicles to pro-
duce IgA, because these follicular structures are not affected
by LTbR-Ig (Yamamoto et al., 2004). Consistent with this possi-
bility, IgA-producing plasma cells are profoundly reduced in the
intestinal lamina propria of LT-a-deficient mice and double-LT-
a-TNF-deficient mice, which lack mesenteric lymph nodes and
isolated lymphoid follicles in addition to Peyer’s patches (Kang
et al., 2002; Ryffel et al., 1998). However, mesenteric lymph
nodes and isolated lymphoid follicles are also not absolutely
required for the initiation of antigen-specific IgA responses.
Indeed, reconstitution of LT-a-deficient mice and double-LT-
a-TNF-deficient mice with bone marrow from normal animalsImmunity 28, June 2008 ª2008 Elsevier Inc. 743
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degree (Kang et al., 2002; Ryffel et al., 1998).
The nonessential role of intestinal follicular lymphoid struc-
tures for the production of IgA is further indicated by studies
with mice lacking inhibitor of DNA binding 2 (Id2), an inhibitor
of helix-loop-helix transcription factors, or retinoic-acid-related
orphan receptor gt (RORgt), a member of the nuclear-receptor
family of transcription factors (Eberl and Littman, 2004). These
proteins are instrumental for the generation of lymphoid-tissue-
inducing cells, a cell type that mediates the formation of orga-
nized intestinal lymphoid tissue through LT-a. Similarly to
bone-marrow-reconstituted LT-a-deficient mice (Kang et al.,
2002), Id2-deficient mice and RORgt-deficient mice have no
Peyer’s patches, mesenteric lymph nodes, and isolated lym-
phoid follicles and yet retain some antigen-specific IgA-produc-
ing plasma cells in the lamina propria (Eberl and Littman, 2004). It
must be noted that in all of these mice, the number of IgA-pro-
ducing plasma cells varies considerably, depending on the
background and rearing conditions. Nonetheless, these models
support the notion that the gut-associated lymphoid tissue can
generate IgA antibodies outside the organized environment of
lymphoid follicles.
IgA Class Switching in the Lamina Propria
The presence of IgA-producing plasma cells in the intestinal lam-
ina propria of mice lacking Peyer’s patches, mesenteric lymph
nodes, and isolated lymphoid follicles points to the lamina prop-
ria as an extrafollicular inductive site for IgA antibodies. Indeed,
the intestinal lamina propria contains IgM+ B cells that may func-
tion as a local precursor of IgA-producing plasma cells (Fagara-
san et al., 2001). These IgM+ precursors comprise naive B cells
that migrate from the bone marrow to the intestine in response
to chemotactic signals generated by intestinal stromal cells
through an LT-mediated NF-kB-inducing kinase (NIK)-depen-
dent pathway (Suzuki et al., 2005). Another subset of IgM+ pre-
cursors is that of gut-experienced IgM+ B cells, which migrate
from Peyer’s patches to the intestinal lamina propria indepen-
dently of stromal signals (Suzuki et al., 2005).
Of note, the intestinal lamina propria of normal but not AID-de-
ficient mice also contains IgA+ B cells, indicating that resident
IgM+ B cells may switch to IgA-producing plasma cells in situ
(Fagarasan et al., 2001). Although still debated (Cerutti, 2008a),
the presence of locally induced IgA class switching is consistent
with the identification of AID transcripts in both IgM+ and IgA+ B
cells from the intestinal lamina propria of an AID-GFP (green fluo-
rescent protein) reporter mouse capable of recapitulating phys-
iological immune responses (Crouch et al., 2007). Active IgA
class switching is also present in the human intestinal lamina
propria. Indeed, this site includes B cells that express AID tran-
scripts and protein and contain extrachromosomal Sa-Sm switch
circles, an episomal DNA byproduct of ongoing IgA CSR (He
et al., 2007).
Another strong indication of the IgA class-switch-inducing ca-
pability of the intestinal lamina propria comes from studies show-
ing abundant production of IgA class-switch-inducing factors by
various cell types dwelling at this site. For instance, intestinal
lamina propria CD4+ T cells were recently shown to produce
large amounts of IL-10, a cytokine involved in IgA class switching
and production (Defrance et al., 1992; Fayette et al., 1997; He744 Immunity 28, June 2008 ª2008 Elsevier Inc.et al., 2007; Kamanaka et al., 2006; Xu et al., 2007). Of note,
CD4+ T cells from the intestinal lamina propria express an acti-
vated phenotype, which possibly results from local activation
by antigen-presenting DCs (Benson et al., 2007). In this regard,
growing evidence indicates that M cell-mediated antigen entry
is not restricted to the follicle-associated epithelium but also oc-
curs in the conventional epithelium in proximity of isolated lym-
phoid follicles (Hamada et al., 2002). In addition to containing
scattered M cells, the conventional epithelium is extensively
infiltrated by DCs, which form transepithelial projections while
capturing antigen in the intestinal lumen (Chieppa et al., 2006;
Rescigno et al., 2001). Uptake of antigen by these DCs may be
followed by its presentation to lamina propria CD4+ T cells, in-
cluding antigen-specific Treg and Tr1 cells, which may thereafter
initiate local IgA responses through CD40L and cytokines,
including IL-10 and TGF-b (Cerutti et al., 1998; Defrance et al.,
1992; Fayette et al., 1997; Li and Flavell, 2008).
Lamina Propria T Independent IgA Responses
Intestinal lamina propria DCs may also present antigen to B cells
(Bergtold et al., 2005), thereby inducing their activation via both
somatically recombined and germline gene-encoded antigen re-
ceptors, including BCR and TLRs. These DCs may further acti-
vate B cells through B cell-activating factor of the TNF family
(BAFF, also known as BLyS) and a proliferation-inducing ligand
(APRIL) (Figure 1), two B cell-stimulating factors structurally
and functionally related to CD40L (He et al., 2007; Litinskiy
et al., 2002; Schneider, 2005; Xu et al., 2007). In both mice and
humans, BAFF and APRIL deliver CD40-independent IgA CSR-
inducing signals via transmembrane activator and calcium-mod-
ulating cyclophilin-ligand interactor (TACI), a receptor that is
preferentially expressed by B cells (Castigli et al., 2005b; Chiu
et al., 2007; He et al., 2003, 2007; Litinskiy et al., 2002; von Bulow
et al., 2001; Xu et al., 2007; Cerutti, 2008b). Growing evidence in-
dicates that this pathway may support intestinal IgA production
in a T cell-independent fashion. Indeed, mice lacking CD40 or T
cells retain intestinal IgA responses to both commensal bacteria
and pathogens, although these responses are decreased com-
pared to those occurring in wild-type animals (Bergqvist et al.,
2006; Macpherson et al., 2000). Similarly, intestinal IgA re-
sponses are partially conserved in humans lacking CD4+ T cells
or CD40 as a result of HIV infection and hyper-IgM syndrome, re-
spectively (He et al., 2007). Conversely, mice lacking APRIL or
TACI and humans expressing mutant TACI molecules exhibit im-
paired IgA responses (Castigli et al., 2004, 2005a; von Bulow
et al., 2001).
Recent data indicate that recognition of bacterial signatures
by TLRs at the intestinal epithelial barrier is essential for the pro-
duction of BAFF and APRIL by lamina propria DCs. Indeed, TLR
signaling not only stimulates DC production of BAFF and APRIL
(He et al., 2007; Xu et al., 2007) but also elicits DC expression of
iNOS (Figure 1), an enzyme that augments BAFF and APRIL syn-
thesis through the generation of nitric oxide (Tezuka et al., 2007).
Recognition of bacteria through TLRs would also account for the
production of BAFF and APRIL by intestinal epithelial cells (He
et al., 2007; Kato et al., 2006; Xu et al., 2007). Intriguingly, epithe-
lial cells further amplify BAFF and APRIL production by stimulat-
ing DCs via TSLP (Figure 1), at least in humans (He et al., 2007;
Xu et al., 2007). Ultimately, BAFF and APRIL would induce IgA
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kines released by DCs or other cell types, including IL-10 and
TGF-b1 (He et al., 2007; Kaminski and Stavnezer, 2006; Litinskiy
et al., 2002; Xu et al., 2007; Cerutti, 2008b). In humans, this pro-
cess appears to be negatively regulated by secretory leukocyte
protease inhibitor (SLPI), a TLR-inducible epithelial factor en-
dowed with both antimicrobial and anti-inflammatory functions
(Xu et al., 2007). These observations indicate that epithelial cells
orchestrate mucosal IgA responses through both positive and
negative regulatory pathways.
B cells undergoing T cell-independent IgA class switching in
the lamina propria would further differentiate into IgA-secreting
plasma cells upon receiving additional signals from BCR ligands,
TLR ligands, and cytokines, including IL-6 and IL-10 (Fagarasan
et al., 2001; Groom et al., 2007; He et al., 2007; Kaminski and
Stavnezer, 2006; Katsenelson et al., 2007; Litinskiy et al., 2002;
Ng et al., 2006; Cerutti, 2008b). In this regard, it must be noted
that IL-6 and IL-10 are produced not only by mucosal DCs but
also by mucosal macrophages, stromal cells, and epithelial cells
(Denning et al., 2007; Fagarasan et al., 2001; He et al., 2007;
Jarry et al., 2008; Xu et al., 2007). Sustained IgA secretion may
also require DC and epithelial cell production of BAFF and APRIL
given that these factors have been shown to deliver plasma cell
survival and differentiation signals via BCMA (B cell maturation
antigen) and TACI (Castigli et al., 2007; O’Connor et al., 2004).
This pathway is likely to be important for the survival of intestinal
IgA-secreting plasma cells generated in the context of both T
cell-independent and T cell-dependent responses.
In mice, T cell-independent IgA responses predominantly in-
volve B-1 cells, a peritoneal IgM+ B cell subset with phenotypic
and functional features distinct from those of conventional B
cells (or B-2) (Hayakawa and Hardy, 1988; Macpherson et al.,
2000; Macpherson and Uhr, 2004). B-1 cells migrate from the
peritoneum to intestinal sites, including the lamina propria, in re-
sponse to microbial TLR ligands (Ha et al., 2006). Consistent with
this possibility, the peritoneal cavity of germ-free mice contains
more B-1 cells that the peritoneal cavity of pathogen-free mice
harboring a diverse intestinal microbiota. In addition to secreting
IgM antibodies in a seemingly natural fashion, B-1 cells produce
IgA antibodies to commensal bacteria upon exposure to antigen.
Indeed, studies in TCR-deficient animals show that B-1 cells ini-
tiate T cell-independent IgA responses upon exposure to DCs
loaded with commensal bacteria (Macpherson and Uhr, 2004).
Whether this response is highly dependent on engagement of
TACI on B-1 cells by BAFF and APRIL remains to be established.
As for humans, the origin, phenotype, and functions of IgM+ B
cells undergoing T cell-independent IgA class switching in the
intestinal lamina propria are not known. Of note, the intestinal
lamina propria from the human colon may also foster sequential
IgA2 class switching and production in IgA1-expressing B cells
originating from colonic lymphoid aggregates (He et al., 2007).
Compared to IgA1, IgA2 may be more appropriate to cope
with the dense flora of the distal intestine, possibly because of
its increased resistance to bacterial proteases (Brandtzaeg
et al., 1999; Mestecky et al., 1999).
Homing of IgA-Producing B Cells to the Intestine
In mice, B cells activated in Peyer’s patches derived from the
bone marrow are distinct from B-1 cells, which originate in theperitoneal cavity (Hayakawa and Hardy, 1988). B-1 and B-2 cells
express distinct phenotypes and carry different Ig receptor rep-
ertoires but contribute equally to IgA production (Kroese et al.,
1989; Stoel et al., 2005). It is becoming clear that IgA antibodies
to T cell-dependent antigens derive mostly from B-2 cells,
whereas IgA antibodies to T cell-independent antigens derive
predominantly from B-1 cells (Fagarasan and Honjo, 2003; Mac-
pherson et al., 2008). This probably reflects different homing
properties of B-1 and B-2 cells, their different thresholds of
activation, and their distinct sites for IgA CSR. Naive B-2 cells
express higher amounts of the intestinal homing receptor a4b7
and slightly lower amounts than T cells of L-selectin, which is re-
quired for homing to peripheral lymph nodes (Andrew et al.,
1996). Interestingly, B and T cells undergo firm adhesion to spe-
cific regions of Peyer’s patches, adhesion being more prominent
in or near follicles for B cells and at interfollicular regions for
T cells (Warnock et al., 2000). This probably contributes to a
greater homing of B cells to Peyer’s patches.
Once activated in Peyer’s patches, B cells that have under-
gone IgA CSR become IgA+ effector B cells, including memory
B cells and plasmablasts (Macpherson et al., 2008). These cells
upregulate the expression of the gut-homing receptors a4b7,
CCR9, and/or CCR10 (Figure 1), recirculate via the thoracic
duct, and home to the intestinal lamina propria (Mora et al.,
2006). Here, a4b7 binds to mucosal addressin cell-adhesion
molecule 1 (MadCAM-1) on endothelial cells, whereas CCR9
and CCR10 respond to TECK (also known as CCL25) and MEC
(CCL2), respectively, two chemokines released by epithelial cells
(Hieshima et al., 2004; Wagner et al., 1996). In the lamina propria,
IgA+ plasmablasts terminally differentiate into IgA-secreting
plasma cells (Brandtzaeg et al., 1999). These plasma cells syn-
thesize the joining (J) chain, which allows the formation of stable
IgA oligomers with increased avidity for antigen (Brandtzaeg,
1974; Mestecky et al., 1971). IgA oligomers bind the pIgR on
the basolateral membrane of epithelial cells through the J chain
and thereafter translocate into the lumen as an SIgA complex
(Figure 1), which comprises the secretory component (Brandt-
zaeg and Prydz, 1984; Mostov and Deitcher, 1986). This poly-
peptide originates from intracellular cleavage of pIgR and medi-
ates binding of SIgA to the mucus layer (Phalipon et al., 2002).
The development of an antigen-specific SIgA response is quite
a long event; 3 to 4 weeks are needed to detect an appreciable
amount of SIgA antibodies in the feces. This could reflect the
long time needed for B cells to get activated, undergo affinity
maturation, leave the Peyer’s patches, recirculate through the
thoracic duct, and reach the final gut destination.
A faster activation of a more primitive IgA response requires
B-1 cells. This mouse B cell subset is characterized by the ex-
pression of CD9, a surface tetraspanin that associates with sur-
face integrins to regulate cell motility (Won and Kearney, 2002).
B-1 cells primarily reside in pleural and peritoneal cavities and
are retained in situ by a concerted action of integrins and CD9
(Ha et al., 2006). After TLR signaling, B-1 cells transiently down-
regulate CD9 and integrins and move in response to chemokines
(Ha et al., 2006). This event provides a first innate immune de-
fense to invading microorganisms through the generation of
a fast wave of TLR-activated B-1 cells migrating to infection sites,
including the gut. Of note, B-1 cells can undergo CSR in situ in the
intestinal lamina propria, which can give rise to IgA-secretingImmunity 28, June 2008 ª2008 Elsevier Inc. 745
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asan et al., 2001). Naive bone-marrow-derived B cells can also
migrate to the lamina propria, but this migration requires the
presence of stromal cells expressing NIK (Suzuki et al., 2005).
Role of IgA in Intestinal Homeostasis
and Immune Protection
Intestinal IgA antibodies serve a variety of functions. In general,
high-affinity IgA antibodies emerging from T cell-dependent
pathways are thought to protect intestinal mucosal surfaces
against colonization and invasion by pathogenic microorgan-
isms (Macpherson et al., 2008; Martinoli et al., 2007). Con-
versely, low-affinity IgA antibodies emerging from T cell-in-
dependent pathways are important to confine commensal
bacteria in the intestinal lumen through a process known as
‘‘immune exclusion’’ (Macpherson et al., 2008). This functional
dichotomy is not absolute. Indeed, T cell-independent IgA (and
IgM) responses provide some degree of immune protection
against certain intestinal pathogens, such as rotavirus (Franco
and Greenberg, 1997). Conversely, strong evidence points to
an important role of T cell-dependent IgA responses in the con-
trol of commensal bacteria (Casola et al., 2004). In addition to
controlling pathogens and commensals, IgA antibodies neutral-
ize microbial products with proinflammatory activity, such
as lipopolysaccharide, in intestinal epithelial cells (Fernandez
et al., 2003). Hence, IgA can play a role both during steady-state
(unperturbed) conditions and infection.
IgA can also mediate apical-to-basolateral transcytosis of an-
tigens across M cells via an unknown receptor or across duode-
nal epithelial cells via the transferrin receptor, also known as
CD71 (Favre et al., 2005; Kadaoui and Corthesy, 2007; Mantis
et al., 2002; Matysiak-Budnik et al., 2008). By promoting ‘‘con-
trolled’’ antigen entry, binding of IgA-antigen immune complexes
by M cells could be critical for the initiation or amplification of in-
testinal immune responses, including IgA production (Favre et al.,
2005). The same pathway could favor neutralization of bacteria in
a cytosolic compartment. Consistent with this possibility, Shi-
gella flexneri, a Gram-negative bacterium unable to spontane-
ously enter the mouse epithelium, was rapidly detected in Peyer’s
patches and mesenteric lymph nodes if coated with specific SIgA
antibodies before its injection in intestinal loops (Kadaoui and
Corthesy, 2007). Yet, under these conditions, the epithelial bar-
rier was preserved and the bacterium was unable to spread to
other nonmucosal tissues. It would be interesting to test whether
entrance of SIgA-coated bacteria also leads to IgA production or
development of tolerance toward the introduced bacteria.
IgA-mediated reverse transcytosis across M cells could target
bacteria to intra- and subepithelial DCs. These DCs may induce
tolerogenic immune responses, including IgA production, with-
out delivering inflammatory signals (Kelsall and Rescigno,
2004), a circumstance that could cause recruitment of immuno-
genic DCs. Unlike intestinal epithelial cells, intestinal DCs ex-
press an IgA receptor complex comprising FcaRI and its signal-
ing subunit FcgR (Monteiro and Van De Winkel, 2003). Triggering
of FcaRI can lead to either inflammatory or noninflammatory re-
sponses, depending on the monovalent or multivalent nature of
the IgA ligand (Pasquier et al., 2005). Binding of monomeric
IgA to FcaRI leads to reduced phosphorylation of an immunotyr-
osine activating motif (ITAM) embedded within the FcRg chain746 Immunity 28, June 2008 ª2008 Elsevier Inc.and elicits recruitment of src homology 2 domain-containing
protein-tyrosine phosphatase-1 (SHP-1), a signal inhibitor that
prevents inflammation by interfering with the activation of multi-
ple signaling pathways (Kanamaru et al., 2008; Pasquier et al.,
2005). Conversely, crosslinking of FcaRI by polymeric IgA
causes inflammation by triggering full phosphorylation of FcgR
and subsequent recruitment of Syk, a protein tyrosine kinase
linked to multiple proinflammatory signaling pathways. Thus,
IgA-containing immune complexes retrotranscytosed across
epithelial cells may initiate noninflammatory or inflammatory
immune responses depending on the monomeric or polymeric
nature of the IgA ligand.
In general, monomeric IgA antibodies are particularly abun-
dant in systemic districts, at least in humans (Macpherson
et al., 2008). These IgA monomers may initiate FcaRI-mediated
noninflammatory responses against bacteria that breach the
mucosal barrier (Pasquier et al., 2005; van Egmond et al.,
2000). On the contrary, IgA polymers may trigger FcaRI-medi-
ated inflammatory responses, particularly when these antibodies
are present in large excess in a nonmucosal context. Indeed, IgA
polymers are frequently found in several autoimmune conditions
and might be an aggravating factor of IgA nephropathy, as re-
cently shown in a spontaneous model of this disease (Kanamaru
et al., 2007). In any case, the Janus-like nature of FcaRI might ex-
plain prior contradictory reports on the ability of IgA to activate
DCs (Geissmann et al., 2001; Heystek et al., 2002).
Of note, IgA-dependent retrotranscytosis can deliver intact
antigen to the basolateral side of epithelial cells (Phalipon and
Corthesy, 2003). This process may be particularly relevant to
the pathogenesis of celiac disease, an intestinal autoimmune
disorder caused by a dysregulated immune response to the glu-
ten protein gliadin. Indeed, CD71-mediated retrotranscytosis of
immunocomplexes comprising intact gliadin peptides and anti-
gliadin IgA antibodies might trigger inflammation as a result of
a progressive accumulation of toxic gliadin peptides in subepi-
thelial districts (Matysiak-Budnik et al., 2008). These peptides
would be completely degraded if transported via fluid-phase
transcytosis, indicating that epithelial cells must tightly control
retrotranscytosis to avoid tissue damage. Such control might
be lost in celiac disease, given that intestinal epithelial cells
from celiac patients display an increased expression of CD71
(Matysiak-Budnik et al., 2008). In addition to gliadin, IgA anti-
bodies from celiac patients target tissue transglutaminase and
connective tissue. However, it must be remarked that IgA defi-
ciency is more frequent among celiac patients (1 in 40) than in
the general population (1 in 400), suggesting a secondary rather
than a primary involvement of IgA in the pathogenesis of this
intestinal disease (Green and Cellier, 2007).
IgA can further participate in intestinal immune homeostasis
by interacting with the local microbiota. It is estimated that the
number of intestinal bacteria is close to 1014 and is one log higher
than that of human cells (Macpherson and Harris, 2004). Mice
kept under germ-free conditions that lack the intestinal micro-
flora have highly reduced intestinal IgA, suggesting a direct
correlation between IgA and commensals. But what is the role
of IgA antibodies? Do they protect the host from commensals?
Or do they shape the composition of the microbiota? IgA could
be implicated in both functions. Indeed, mice lacking the pIgR
have no fecal IgA or IgM and display an increased penetration
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commensals (Johansen et al., 1999). In this regard, it is important
to note that IgA usually limits the penetration of intestinal bacteria
to mesenteric lymph nodes (Macpherson and Uhr, 2004). In
addition, AID-deficient mice lacking somatically mutated SIgA
have an aberrant expansion of anaerobic bacteria in the small
intestine, whereas mice lacking the pIgR show no changes in
their microbiota (Fagarasan et al., 2002; Johansen et al., 1999).
IgA antibodies to commensal bacteria can also limit the inflam-
matory response of intestinal immune cells. This conclusion was
suggested by results generated in the following experimental
system. Germ-free mice on a RAG-deficient background (i.e.,
with no B and T cells) were monoassociated with Bacteroides
betaiotaomicron in the presence of absence of a hybridoma
backpack releasing bacteria-specific SIgA in the intestinal lumen
(Peterson et al., 2007). The effect was dramatic in both the host
and the bacteria. In the host, SIgA significantly decreased the ox-
idative burst. In bacteria, SIgA downregulated the expression of
the targeted epitope and decreased the expression of genes in-
volved in nitric-oxide metabolism, without inducing cell death or
growth arrest. Thus, IgA to a specific bacterial epitope may have
a profound effect not only on the expression of that epitope, but
also and on the oxidative response elicited by that epitope.
In principle, a dysregulation of intestinal antibody responses to
commensal bacteria might result in an excessive innate immune
response, which in turn could precipitate or aggravate intestinal
inflammation. For instance, in patients with Crohn’s disease, IgG
and IgA antibodies to Saccharomyce Cerevisiae or microbial fla-
gellin could play a role in shaping the microbiota (Lodes et al.,
2004; Zholudev et al., 2004), with effects on both the host and
the microorganisms, including excessive activation of the innate
immune response. Altogether, the available evidence suggests
that IgA is important not only to confine bacteria in the intestinal
lumen, but also to shape the overall composition of the intestinal
microbiota. A dysregulation of these processes may trigger
inflammatory disorders like celiac disease, IgA nephropathy,
and Crohn’s disease.
Conclusions
Growing evidence indicates that intestinal IgA antibodies provide
immune protection by functioning through both high-affinity and
low-affinity modes. It is also becoming increasingly clear that
the intestinal mucosa utilizes multiple follicular and extrafollicular
sites as well as multiple T cell-dependent and T cell-independent
pathways to generate protective IgA responses. More studies are
needed tobetterdefine the relative contribution of thesepathways
to the induction of protective IgA responses to pathogens, com-
mensals, and dietary antigens. It is also of paramount importance
to better understand the mechanisms through which IgA anti-
bodies exert their protective role in a noninflammatory manner.
In this regard, intestinal IgA are thought to lack complement-fixing
activity, and intestinal macrophages seemingly lack proinflamma-
tory IgA receptors (Macpherson et al., 2008). Although these fac-
tors are certainly important to limit inflammation, the mechanisms
by which IgA strikes the balance between immune protection and
immune tolerance at intestinal sites remain unclear.
Remarkably, a substantial proportion of patients affected with
IgA deficiency develop intestinal inflammation as well as autoim-
mune, allergic, and mucosal B cell lymphoproliferative disordersin addition to mucosal infections (Cunningham-Rundles and
Knight, 2007; Daniels et al., 2007). This evidence indicates that
IgA is important not only for the establishment of intestinal
immune homeostasis and immune protection, but also for the
control of autoreactive, proinflammatory, and neoplastic B cell
clones present in both intestinal and systemic districts. Such
control might involve a crosstalk between Treg, Tr1, and Th17
cells and IgA-producing B cells or their precursors. A better un-
derstanding of this crosstalk may help develop novel mucosal
vaccines as well as more effective therapies for the treatment
of intestinal inflammatory disorders.
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